The message reads, in part:
“The past years have been a period of dynamic development and significant, impressive achievements for your company. Today, thanks in large part to the professionalism of its employees and the broad introduction of innovative methods and approaches, BIOCAD is rightly regarded as one of the industry leaders. You carry out the full cycle of development, research and production of effective medicines for the treatment of oncological, autoimmune, hereditary and socially significant diseases, and do much to improve access to high-tech medical care.
It is gratifying to see that the company’s team is not resting on its laurels and is successfully implementing new and promising projects. This important and much-needed work, as well as your significant contribution to the development of the pharmaceutical industry and national healthcare as a whole, deserve the highest recognition.”